Results 181 to 190 of about 31,041 (297)
This systematic review explores the application of artificial intelligence and machine learning in left ventricular assist device implantation, highlighting their superior accuracy in predicting mortality, adverse events, myocardial recovery, thrombosis risk, and right ventricular failure. Despite promising outcomes, challenges like data heterogeneity,
Usama Hussain +7 more
wiley +1 more source
Impact of spontaneous recanalization of occlusive cervical artery dissection on risk of stroke. [PDF]
Mayer-Suess L +10 more
europepmc +1 more source
The incidence of serious complications after selective laser trabeculoplasty
Abstract Purpose To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT). Methods All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018.
Eeva S. Ojanen +2 more
wiley +1 more source
Optimizing Antiplatelet Therapy in Coronary Interventions [PDF]
Spencer B. King
openalex +1 more source
Abstract Purpose To evaluate the incidence, outcomes, and risk factors of numerical hypotony (NH) and choroidal effusion (CE) following standalone PRESERFLO MicroShunt (PMS) implantation. Methods Primary open‐angle glaucoma (POAG) and pseudoexfoliative glaucoma (PXG) patients with uni‐ or bilateral surgery at a tertiary university hospital were ...
Emil Nasyrov +5 more
wiley +1 more source
Intravenous thrombolysis before endovascular treatment in acute posterior circulation occlusions, what's next? [PDF]
Frol S +3 more
europepmc +1 more source
Antiplatelet therapy in coronary artery disease: Review and update of efficacy studies
James E. Tisdale
openalex +1 more source
Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization [PDF]
Sylvia Bellucci +10 more
openalex +1 more source
Summary Ibrutinib is metabolized by cytochrome P450 3A (CYP3A) and poses challenges with drug interactions. We conducted a population‐based cohort study of Ontario residents aged ≥66 years who initiated ibrutinib for chronic lymphocytic leukaemia (CLL) to evaluate the frequency of potential drug interactions involving moderate/strong CYP3A inhibitors ...
Tuan Hoang +10 more
wiley +1 more source

